Girl, 13, Begged Father For Money To Treat Cancer. Video Viral After Death

Girl, 13, Begged Father For Money To Treat Cancer. Video Viral After Death

Sai Shri’s parents had been separated for eight years and she had been living with her mother

“Daddy…please do something and save me” – says a 13-year-old girl in an incredibly tragic WhatsApp video to her father, begging him for money for her cancer treatment. Young Sai Shri died on Sunday in Andhra Pradesh’s Vijayawada, but her tearful voice is being heard by thousands through the video that has been widely shared online.

Sai Shri’s parents had been separated for eight years and she had been living with her mother. In the video, she pleads with her father, Shetty Shivakumar, to sell her home – which was in her name – to raise money for her treatment. Her mother had reportedly tried to sell the house but was stopped by her father, who allegedly got help from a politician to try and throw his estranged family out.

Sai was diagnosed with cancer in August, and doctors reportedly told her mother that a bone marrow transplant was the only option.

Speaking in Telugu in the excruciating video, she shows swellings and lesions on her arms and legs and shares that she is in great pain.

“Daddy, you say that you don’t have money. At least we have this house. Please sell this house and pay for my treatment daddy. Or else, they (doctors) say that I won’t survive for long,” she weeps.

“I haven’t gone to school in months. I want to play with my friends…I want to go to school…take my exam…I want to become a doctor…”

Based on a complaint by an activist, the Andhra Pradesh State Human Rights Commission has asked the police to investigate whether Mr Shivakumar, who lives in the same city, was guilty of neglecting his daughter.

Activists allege that Mr Shivakumar refused to spend money for his daughter’s treatment even though he could afford it.

Sai’s mother Sumashri had reportedly spent Rs. 30 lakh but the treatment was not good enough for the type of cancer that she was suffering from.


Lenovo Phab 2 Plus review: A treat for audiophiles

The phablet comes with features like 'Smart Assist' for one-handed mode.
The phablet comes with features like ‘Smart Assist’ for one-handed mode.


  • Lenovo-Motorola in talks with Android Pay, Paytm to integrate payment solutions
NEW DELHI: In the crowded smartphone market for 5 and 5.5-inch displays, there is a dedicated space for those who love to have phablets in their digital lives. Chinese smartphone maker Lenovo recently expanded its Phab series with Phab 2 Plus which is strictly for those looking for heavy media consumption.

The Rs 14,999 device is in direct contest with Xiaomi’s Mi Max that has the same specifications and price and was launched in May 2016.

Is Lenovo better than Mi Max? Let’s find out.

Phab 2 Plus has an all-metal body with a Gorilla Glass display and curvy back. The 6.44-inch display is quite immersive at maximum brightness. Even though the device offers a one-handed mode, you actually need to use both hands to work seamlessly on it.

The fingerprint scanner at the back panel is very responsive. There is a hybrid SIM tray on the left and volume and power buttons at right.

The striking feature that differentiates Phab 2 Plus from Mi Max is its rear dual-camera setup with LED flash.

Phab 2 Plus, however, comes with the not-so-popular octa-core MediaTek processor (MT8783), 3GB of RAM and 32GB of storage. The device runs on the near-stock Android Marshmallow.

In Settings, you can find features like “Smart Assist” for one-handed mode, change volume when picking up the phone and auto-answer a call.

The device performed brilliant during constant gaming, long movie-watching hours or surfing.

The Dolby Atmos audio is one of the striking features. The app lets you choose from multiple sound profiles. Phab 2 Plus ships with JBL earphones that deliver decent audio quality (we suggest that users consume content that has Dolby support).

Lenovo Phab 2 Plus features two 13-megapixel camera sensors. Lenovo claimed that the secondary camera provides depth in a photo and it was right. The continuous autofocus works well even with video.

The AR camera seems to be inspired by augmented-reality game “Pokemon Go”.

Mi Max, however, scores with 4,850mAh battery. Lenovo’s 4,050mAh battery delivered nearly 19-hour backup during a marathon session of content consumption.

In the loop test, the device returned four hours 39 minutes when we played two full-HD movies.

What doesn’t work?

Phab 2 Plus heats up easily, has a smaller battery as compared to its only competition in the Indian market and the dual-camera setup is not very impressive.

Conclusion: The positives will surely make the choice difficult between Phab 2 Plus and Mi Max. If you are an audiophile, go for Phab 2 Plus. The near-stock Android is a treat.

Want stories like this in your inbox? Sign up for the weekly ET Panache newsletter.

Neem extract may help treat pancreatic cancer: study

Nimbolide was able to reduce the migration and invasion capabilities of pancreatic cancer cells by 70%. Photo:Nimbolide was able to reduce the migration and invasion capabilities of pancreatic cancer cells by 70%. Photo:

Houston: A natural extract derived from the neem tree, commonly found in India, could potentially be used to treat pancreatic cancer without harming normal, healthy cells, a new study has claimed.

Scientists tested nimbolide, a compound found in neem leaves, against pancreatic cancer in cell lines and mice. The results showed that nimbolide can stop pancreatic cancer’s growth and metastasis without harming normal, healthy cells.

“The promise nimbolide has shown is amazing, and the specificity of the treatment towards cancer cells over normal cells is very intriguing,” said Rajkumar Lakshmanaswamy from the Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso).

Researchers observed that nimbolide was able to reduce the migration and invasion capabilities of pancreatic cancer cells by 70%; meaning the cancerous cells did not become aggressive and spread.

According to researchers, that is promising. In humans, this migration and invasion-or metastasis-of pancreatic cancer to other regions of the body is the chief cause of mortality. Nimbolide treatments also induced cancer cell death, causing the size and number of pancreatic cancer cell colonies to drop by 80%.

“Nimbolide seems to attack pancreatic cancer from all angles,” said Lakshmanaswamy. One of the most important findings is that nimbolide did not harm healthy cells in both the in vitro and in vivo experiments, researchers said.

Pancreatic cancer has the highest mortality rate of all cancers with 94% of patients dying within five years of diagnosis. The cancer grows quickly and there are currently no effective treatments available, underscoring the importance of finding new therapies.

“Many people in India actually eat neem and it does not have harmful side effects, which suggests that using nimbolide for pancreatic cancer will not cause adverse effects like chemotherapy and radiation typically do,” said Ramadevi Subramani from TTUHSC El Paso.

The findings were published in the journal Scientific Reports.